Maryam Noroozian
Maryam Noroozian is an expert in Psychiatry at Tehran University of Medical Sciences (Iran). As of October 2026, ScienceLeadR ranks Maryam Noroozian in the top 1% of experts in Iran for Cognitive Dysfunction, Cognition Disorders and Alzheimer Disease. Maryam Noroozian has authored 123 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 305 (community average: 125). How the SLR is computed.
LeadR Profile
Psychiatry
Subspecialties: Neurology - Psychology - Geriatrics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1997 - 2026
Number : 123
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Conventional MRI Markers and Cognitive Dysfunction in Multiple Sclerosis: An Exploratory Pilot Study. PMID 42922187 — pilot projects, sclerosis, multiple sclerosis, pilots, atrophy, neuropsychological tests, magnetic resonance imaging, cognitive dysfunction, wounds and injuries | Brain Behav | 2026 | 0 |
| Chronic schizophrenia versus Alzheimer's disease: neuroimaging perspectives on the late-life course of schizophrenia. PMID 42489907 — white matter, comorbidity, dementia, cholesterol, ldl, neuroimaging, alzheimer disease, aging, brain, cognitive dysfunction, schizophrenia, risk factors, diagnosis, antipsychotic agents, synaptic transmission | J Neural Transm (Vienna) | 2026 | 1 |
| From MRI to 3D printing: a tangible neuroeducational tool for visualizing hippocampal morphology and Alzheimer's disease progression. PMID 42133009 — hippocampus, atrophy, alzheimer disease, disease progression, cognitive dysfunction, printing, printing, three-dimensional, education, synaptic transmission | J Neural Transm (Vienna) | 2026 | 0 |
| Structural MRI in frontotemporal dementia and Alzheimer's disease: stage-dependent atrophy patterns. PMID 42082780 — dementia, atrophy, frontotemporal dementia, alzheimer disease, biomarkers, synaptic transmission | J Neural Transm (Vienna) | 2026 | 0 |
| Montreal Cognitive Assessment (MoCA) Scale: Strengths, Limitations, and Implication for Clinical Practice. PMID 42051279 — cognitive dysfunction, methylenebis(chloroaniline), psychometrics, mental status and dementia tests | Iran J Psychiatry | 2026 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map